Cocrystal powder technologies for best-in-class bioavailability and stability – white paperCocrystal powder technologies for best-in-class bioavailability and stability – white paper
Specialized cocrystal powder technologies offer unprecedented solutions for ingredients with poor stability and low bioavailability. This white paper examines the science behind Cocrystal Technology Company’s patented platform and nutraceutical actives, with a particular focus on Crystal QH® Ubiquinol.
November 16, 2023
Sponsored by Cocrystal Technology
Backed by 60 global patents granted or pending and nearly 100 published papers, Cocrystal Technology’s active powder technologies offer nutraceutical manufacturers a new option for demonstrated best-in-class bioavailability and superior in-formula stability. Built on 13 years of research by a team of over 30 scientists, these actives are produced in a state-of-the-art, NSF-certified manufacturing facility. The powders also feature pure natural integrity and generally improved solubility, dissolution, melting point and flowability versus existing offerings.
Learn more about the science and data behind these cost-effective and supply-ready solutions, including Crystal QH® Ubiquinol. Download now!
Read more about:White Papers
You May Also Like
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023
Ashwagandha: Roots for wellness, leaves for soil – articleNov 28, 2023
Creatine, whey protein, beta-alanine among picks in NFL-style draft at SupplySide WestDec 01, 2023
Unleash the power of ‘combos’ supplements to meet consumer demand – infographicNov 22, 2023